| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/17/2013 | US20130017170 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 01/17/2013 | US20130017169 Multimeric forms of therapeutic proteins and uses thereof |
| 01/17/2013 | US20130017168 Methods for enhancing the efficacy of il-2 mediated immune responses |
| 01/17/2013 | US20130017148 Systems for producing multilayered particles, fibers and sprays and methods for administering the same |
| 01/17/2013 | US20130017147 Targeting agent for tumor site |
| 01/17/2013 | CA2857369A1 Fully human antibodies against human cd20 |
| 01/17/2013 | CA2841864A1 Novel anti-cancer isocarbostyril alkaloid conjugates |
| 01/17/2013 | CA2841516A1 Novel zinc finger-like peptide compositions as potent agents in cancer prevention and treatment |
| 01/17/2013 | CA2841445A1 A heat stable oxygen carrier-containing pharmaceutical composition for different treatment applications |
| 01/17/2013 | CA2841238A1 Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors |
| 01/17/2013 | CA2841111A1 Novel pyrrolo pyrimidine derivatives |
| 01/17/2013 | CA2841080A1 Inhibitors of bruton's tyrosine kinase |
| 01/17/2013 | CA2839747A1 Eosinophil peroxidase compositions and methods of their use |
| 01/17/2013 | CA2839395A1 Aminomethyl quinolone compounds |
| 01/16/2013 | EP2546651A1 Modulator compounds of the drug resistance in epithelial tumour cells |
| 01/16/2013 | EP2546345A1 DNA encoding polypeptide involved in biosynthesis of herboxidiene |
| 01/16/2013 | EP2546269A1 Monoclonal antibody against necrosis marker prdx4 and use thereof |
| 01/16/2013 | EP2546266A1 MONOCLONAL ANTIBODY AGAINST NECROSIS MARKER ERp29 AND USE THEREOF |
| 01/16/2013 | EP2546249A1 5-Alkynyl-pyridines |
| 01/16/2013 | EP2546248A1 Crystal form H of imatinib mesylate |
| 01/16/2013 | EP2546247A1 Imatinib mesylate preparation procedure |
| 01/16/2013 | EP2546239A1 6-amino isoquinolins compounds and methods for making the same |
| 01/16/2013 | EP2546238A1 6-amino isoquinolins compounds and methods for making the same |
| 01/16/2013 | EP2546237A1 7-amino isoquinolins compounds and methods for making the same |
| 01/16/2013 | EP2546233A1 Hydrobenzamide derivatives as inhibitors of HSP90 |
| 01/16/2013 | EP2545964A1 Novel FXR (NR1H4) binding and activity modulating compounds |
| 01/16/2013 | EP2545938A1 Therapeutic use of anti-tweak receptor antibodies |
| 01/16/2013 | EP2545921A2 Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms |
| 01/16/2013 | EP2545918A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 01/16/2013 | EP2545911A1 Use of Lipoteichoic Acid in the Treatment of Non-Encapsulated Cancer Cells |
| 01/16/2013 | EP2545910A1 Use of Lipoteichoic Acid in the treatment of cancer in an inflammatory state |
| 01/16/2013 | EP2545909A1 Combination of D-Amino Acids and Lipoteichoic Acid |
| 01/16/2013 | EP2545174A2 Methods and compositions containing fc fusiong proteins for enhancing immune responses |
| 01/16/2013 | EP2545052A1 Imidazopyridines syk inhibitors |
| 01/16/2013 | EP2545047A1 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| 01/16/2013 | EP2545038A1 Hydrated crystalline forms of n-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
| 01/16/2013 | EP2544768A1 Anti-cancer agent delivery vehicles capable of improved laoding |
| 01/16/2013 | EP2544720A1 Carbohydrate-polyamino acid-drug conjugates |
| 01/16/2013 | EP2544704A2 Sparc angiogenic domain and methods of use |
| 01/16/2013 | EP2544699A2 A novel method for delivery and use of isothiocyanates for prophylaxis and/or therapy of bladder cancer |
| 01/16/2013 | EP2544692A1 Use of tigecycline for treatment of cancer |
| 01/16/2013 | EP2544687A1 Methods for the treatment of non-hodgkin's lymphomas using lenalidomide, and gene and protein biomarkers as a predictor |
| 01/16/2013 | EP2544686A2 Combination methods for treatment of disease |
| 01/16/2013 | EP2544683A2 Synergistic effect of tocotrienols and curcumin |
| 01/16/2013 | EP2544682A1 Phytocannabinoids in the treatment of cancer |
| 01/16/2013 | EP2544680A2 Use of erbb3 inhibitors in the treatment of triple negative and basal-like breast cancers |
| 01/16/2013 | EP2544678A2 Inhibitors of glucose metabolism for use in the treatment of birt-hogg-dubé syndrome |
| 01/16/2013 | EP2544676A1 The use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas |
| 01/16/2013 | EP2544674A1 Cdc7 kinase inhibitors and uses thereof |
| 01/16/2013 | EP2544672A1 Combination anti-cancer therapy |
| 01/16/2013 | EP2544663A2 Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
| 01/16/2013 | EP2544542A1 Analgesic compounds, compositions, and uses thereof |
| 01/16/2013 | EP2544541A1 Combination therapy for treating breast cancer |
| 01/16/2013 | EP2281822B1 New dihydroindolone derivatives, method of preparing same and pharmaceutical compositions containing them |
| 01/16/2013 | CN1954073B Modified Bouganin proteins, cytotoxins and methods and uses thereof |
| 01/16/2013 | CN102884194A Methods and compositions containing Fc fusiong proteins for enhancing immune responses |
| 01/16/2013 | CN102884085A Anti-ERBB3 antibodies |
| 01/16/2013 | CN102884082A Neutralizing prolactin receptor antibodies and their therapeutic use |
| 01/16/2013 | CN102884072A Substituted androst-4-ene diones |
| 01/16/2013 | CN102884066A Salts and polymorphs of 8-fluoro-2-{4-[(methylamino}methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one |
| 01/16/2013 | CN102884062A Aminopyrimidine kinase inhibitors |
| 01/16/2013 | CN102884060A Heterocyclic compounds useful for kinase inhibition |
| 01/16/2013 | CN102884041A Cationic lipid |
| 01/16/2013 | CN102883750A 选择性整联蛋白抑制剂 Selective integrin inhibitors |
| 01/16/2013 | CN102883747A Novel antibody to a carbonic anhydrase |
| 01/16/2013 | CN102883746A Cancer treatment |
| 01/16/2013 | CN102883739A Analogs of pitutary adenylate cyclase-activating polypeptide (PACAP) and methods for their use |
| 01/16/2013 | CN102883720A Method of treating pancreatic cancer |
| 01/16/2013 | CN102876778A Application of APP genes in preparing early definitive t(8;21)/AML1/ETO+AML prognostic preparation |
| 01/16/2013 | CN102876770A Tumor metastasis marker gene and application thereof |
| 01/16/2013 | CN102876697A Nano cationic liposome carrying FL gene recombinant plastid, and preparation method and application of nano cationic liposome |
| 01/16/2013 | CN102876681A Nucleic acid aptamer for targeted medicament carrier |
| 01/16/2013 | CN102876631A Method for separating immune cells from blood and application of method to disease treatment |
| 01/16/2013 | CN102876456A Method for extracting volatile oil and alkaloid from pepper by using subcritical fluid |
| 01/16/2013 | CN102875689A Preparation method and application of ophiopogon japonicus polysaccharide |
| 01/16/2013 | CN102875685A Chimeric antigen receptor hFVIIL-CD8-OX40-CD3zeta and application thereof |
| 01/16/2013 | CN102875684A FGFR single-stranded antibody fusion protein and application thereof in preparing targeting tumor cells medicines |
| 01/16/2013 | CN102875681A Anti-alpha v beta 6 antibodies and uses thereof |
| 01/16/2013 | CN102875680A Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 01/16/2013 | CN102875678A Human anti-human CD20 monoclonal antibody molecule and application thereof |
| 01/16/2013 | CN102875677A Humanized anti-egfl7 antibodies and methods using same |
| 01/16/2013 | CN102875676A Human anti-human VEGF monoclonal antibody molecule and application thereof |
| 01/16/2013 | CN102875651A Anti-tumor target-activated polypeptide doxorubicin and preparation method and application thereof |
| 01/16/2013 | CN102875645A Thymic humoral factor THF-gamma2, its derivative, their synthetic method, and their application in antitumor drugs |
| 01/16/2013 | CN102875642A Compounds for enzyme inhibition |
| 01/16/2013 | CN102875633A Betulonic acid ester derivative and preparation method and application thereof |
| 01/16/2013 | CN102875632A Ursolic acid ester derivatives and preparation methods and applications thereof |
| 01/16/2013 | CN102875606A Copper diphosphonate complex and preparation method and application thereof |
| 01/16/2013 | CN102875570A Quinazoline derivative, and preparation method and application thereof |
| 01/16/2013 | CN102875569A Isoxazole pyrimidone (or triazone) compounds with herbicidal activity and anti-liver cancer activity |
| 01/16/2013 | CN102875565A Esterified podophyllum derivative with antitumor activity and preparation method and usage of esterified podophyllum derivative |
| 01/16/2013 | CN102875564A Nitrogen substitution podophyllum type derivatives with antitumor activity and preparation method and application thereof |
| 01/16/2013 | CN102875560A 5-substituted tetrandrine compound and application thereof in preparing anticarcinogen sensitizer |
| 01/16/2013 | CN102875558A 2-chloro-4-substituted-8-nitrobenzofuran [3,2-d] miazines compound, preparation method of compound and application of compound |
| 01/16/2013 | CN102875556A (4S)-1-substituted-2,5-diazabicyclo[2,2,1] heptane derivative and preparation method thereof |
| 01/16/2013 | CN102875549A 7-arylamine/methylamino-5-amino-6-azaindole derivative, preparation method and application |
| 01/16/2013 | CN102875535A 1,5-[(substituted)-methano]-tetrahydro-1H-pyrrole[1,2-c]-imidazole-3(2H)-ketone derivative and preparation method thereof |
| 01/16/2013 | CN102875523A 丹参丹酚酸f衍生物及药用用途 Salvia Sal f derivatives and medicinal uses |
| 01/16/2013 | CN102875518A Genipin methyl ether, preparation method and medicine application thereof |
| 01/16/2013 | CN102875513A Microcrystal catechin and preparation method thereof |